Download our 2022 Q1 Quarterly Drug Pipeline Report
Our quarterly pipeline report provides insight into specialty and traditional drugs in development that are expected to launch within the next twelve months, with a focus on medications currently in Phase III studies. The report is a helpful tool for your team to keep updated on the latest drugs to market and to plan pharmacy benefits.
Our report is broken into four sections to help your team:
- Generic Launch
- Specialty and Traditional
- New-drug Indication
- Comments & Insights Section
The Generic Launch section details which branded drugs will be released as first-time generics, their estimated date of release or loss of exclusivity, and the number of manufacturers competing for the generic alternatives. We also provide financial data that shows the 2020 sales for the brand drugs.
The information provided is for informational purposes only and should not be solely relied upon for decision-making purposes.